期刊文献+

肿瘤标志物CEA、CA125、CA199在恶性胸腔积液鉴别中的应用分析 被引量:2

Application analysis of tumor markers CEA,CA125,CA199 in differential diagnosis of malignant pleural effusions
下载PDF
导出
摘要 目的探究良恶性胸腔积液中血清及胸腔积液癌胚抗原(CEA)、糖类抗原125(CA125)及糖类抗原199(CA199)水平差异,并为临床诊断积累实践性经验。方法回顾性分析该院于2010年2月至2014年3月收治的125例胸腔积液患者,根据积液性质划分为良性组(49例)及恶性组(76例)。记录两组胸腔积液病因构成、胸腔积液及血清肿瘤标志物水平,同时计算胸腔积液中的肿瘤标志物诊断效能。结果胸腔积液CEA、CA125、CA199联合检测对良、恶性胸腔积液的诊断特异度90.6%、灵敏度95.1%、阳性预测值90.2%、阴性预测值95.3%及准确度92.7%,均高于单独检测各项肿瘤标记物及任意2项标志物联合诊断。结论胸腔积液中CEA、CA125及CA199三项指标联合诊断,有利于良、恶性胸腔积液的辅助诊断。 Objective To explore the difference of serum and pleural effusion CEA ,CA125 and CA199 levels in benign and ma‐lignant pleural effusions to accumulate the practical experience for clinical diagnosis .Methods 125 patients with pleural effusion in this hospital from February 2010 to March 2014 were performed the retrospective analysis and divided into the benign group(49 ca‐ses) and malignant group(76 cases) according to the nature of the fluids .The etiology composition ,pleural effusion and serum tumor markers levels were recorded in the two groups and at the same time the diagnosis efficiency of the tumor markers in pleural effusion was calculated .Results The specificity of the combined detection of CEA ,CA125 and CA199 for diagnosing benign and malignant pleural effusion was 90 .6% ,the sensitivity was 95 .1% ,the positive predictive value was 90 .2% ,negative predictive val‐ue was 95 .3% and accuracy was 92 .7% ,which were higher than those of the single index detection and any 2‐marker combined de‐tection .Conclusion The combined diagnosis of CEA ,CA125 and CA199 in pleural effusion conduces to the assisted diagnosis of be‐nign and malignant pleural effusion .
作者 杨健
出处 《国际检验医学杂志》 CAS 2015年第6期772-773,共2页 International Journal of Laboratory Medicine
关键词 癌胚抗原 糖类抗原 胸腔积液 诊断 生化指标 carcinoembryonic antigen carbohydrate antigen pleural effusion diagnosis biochemical index
  • 相关文献

参考文献11

二级参考文献32

共引文献37

同被引文献16

  • 1姜晓明,陈爽,杜晓艳,鞠晓红.5种血清肿瘤标志物检测在肺癌诊断中的临床价值[J].吉林医药学院学报,2013,34(2):81-84. 被引量:28
  • 2THOMAS D S , FOURKALA E O , Apostolidou S, et al. Evalua- tion of serum CEA, CYFRA21 - 1 and CA125 for the early detec- tion of colorectal cancer using longitudinal preclinical samples [ J ]. British journal of cancer, 2015,113 (2) :268 - 274.
  • 3Budd R, Acharya N, Malik M. The impact of malignant pleural effu- sion a retrospective review [ J ]. Eur Respir,2011,9 ( 38 ) : 2839.
  • 4Thomas JM, Musani AI. Malignant pleural effusions : a review [ J ]. Clinics in Chest Medicine,2013,34(3 ) :459 -471.
  • 5Donnem T,Andersen S,A1 Saad S,et al. Prognostic impact of angio- genic markers in non small cell lung cancer is related to tumor size [ J ]. Clinical Lung Cancer,2011,12 (2) : 106 - 115.
  • 6Antonangelo L,Sales RK, Cora AP,et al. Pleural fluid tumour mark- ers in malignant pleural effusion with inconclusive cytologic results [ J ]. Current Oncology ,2015,22 ( 5 ) : 336 - 341.
  • 7Azimi Q, Rezadoost B, Nadoushan M J, et al. Evaluation of serum cy- fra 21 in patients with pleural effusion [ J]. Iranian Red Crescent Medical Journal ,2012,14 (10) :613 - 616.
  • 8Liu Lei, Liu Bin, Zhu Lili, et al. Clinical significance of CYFRA2 l - 1, Scc - Ag and telomerase activity in serum and pleural effusion of patients with squamous - cell lung cancer[ J ]. Bioanalysis ,2012, 4(19) :2367 -2374.
  • 9李耀军,文凌娟.肿瘤标记物在不同病理类型肺癌中表达意义[J].中华实用诊断与治疗杂志,2011,25(2):176-177. 被引量:11
  • 10展翼翼,朱红革,刘春玲.肺癌诊断和监控治疗中血清肿瘤标记物联合动态检测的临床价值[J].中国肿瘤临床与康复,2014,21(4):410-411. 被引量:3

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部